Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page’s footer/site release revision was updated from v3.5.2 to v3.5.3, indicating a platform or template version change rather than a modification to the study record.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no other page content changes are indicated.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No study content or core page functionality appears to be altered.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page shows an updated revision: v3.4.3 replaces the previous v3.4.2. This is a backend/versioning update and does not alter clinical trial details presented.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.4.2 and the prior government-funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedA site-wide funding notice regarding government funding and operations was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.